07/07/2025
12:19 PM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
05/20/2025
3:14 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
2:29 PM | ARMISTICE CAPITAL, LLC (Filed by)
Ironwood Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
05/13/2025
10:32 AM | Ironwood Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
05/07/2025
6:11 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
10:13 AM | Ironwood Pharmaceuticals (Subject)
Pacer Advisors, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
05/02/2025
9:42 AM | Ironwood Pharmaceuticals (Subject)
Pacer Advisors, Inc. (Filed by)
| Form SCHEDULE 13G | |
04/28/2025
4:27 PM | Ironwood Pharmaceuticals (Filer)
| Form DEF 14A | |
04/28/2025
4:27 PM | Ironwood Pharmaceuticals (Filer)
| Form DEFA14A | |
04/28/2025
4:29 PM | Ironwood Pharmaceuticals (Filer)
| Form ARS | |
04/25/2025
6:18 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for IRWD and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ironwood Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
04/14/2025
6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2025
11:19 AM | BlackRock, Inc. (Filed by)
Ironwood Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/27/2025
6:08 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:49 PM | ARMISTICE CAPITAL, LLC (Filed by)
Ironwood Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
8:00 PM | Ironwood Pharmaceuticals (Issuer)
Martini Gregory S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:00 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:00 PM | Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:00 PM | Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
8:00 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:27 AM | Ironwood Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
01/31/2025
10:44 AM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/29/2025
4:29 PM | Ironwood Pharmaceuticals (Issuer)
Martini Gregory S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/29/2025
4:30 PM | Ironwood Pharmaceuticals (Issuer)
Martini Gregory S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
4:30 PM | Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
3:10 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2025
3:38 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:35 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:43 PM | Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
3:05 PM | DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
4:00 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
1:41 PM | Ironwood Pharmaceuticals (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SCHEDULE 13G | |
11/12/2024
2:47 PM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Ironwood Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
4:22 PM | Ironwood Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
10:46 AM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/16/2024
9:04 AM | Ironwood Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
09/30/2024
6:00 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:05 PM | DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom (Ad) Obscure Metal More Valuable than Gold and Bitcoin… COMBINED?
This strange "AI Metal" holds the key to the $100 trillion AI boom.
Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world.
And you won't believe what he uncovered. Click here to see the details because this could be the biggest tech story of this decade. |
08/08/2024
6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
